These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 37176104)

  • 1. Systemic Metabolism and Mitochondria in the Mechanism of Alzheimer's Disease: Finding Potential Therapeutic Targets.
    Song M; Fan X
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial dysfunction in Alzheimer's disease: Role in pathogenesis and novel therapeutic opportunities.
    Perez Ortiz JM; Swerdlow RH
    Br J Pharmacol; 2019 Sep; 176(18):3489-3507. PubMed ID: 30675901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial dysfunction: the missing link between aging and sporadic Alzheimer's disease.
    Grimm A; Friedland K; Eckert A
    Biogerontology; 2016 Apr; 17(2):281-96. PubMed ID: 26468143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting mitochondrial bioenergetics for Alzheimer's prevention and treatment.
    Yao J; Brinton RD
    Curr Pharm Des; 2011; 17(31):3474-9. PubMed ID: 21902662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent trends of natural based therapeutics for mitochondria targeting in Alzheimer's disease.
    Dhiman A; Handa M; Ruwali M; Singh DP; Kesharwani P; Shukla R
    Mitochondrion; 2022 May; 64():112-124. PubMed ID: 35367397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Advances of Mitochondrial Alterations in Alzheimer's Disease: A Perspective of Mitochondrial Basic Events.
    Wei W; Jiang Y; Hu G; He Y; Chen H
    J Alzheimers Dis; 2024; 101(2):379-396. PubMed ID: 39213063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Of Energy and Entropy: The Ineluctable Impact of Aging in Old Age Dementia.
    Boccardi V; Comanducci C; Baroni M; Mecocci P
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29232829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disentangling Mitochondria in Alzheimer's Disease.
    Johri A
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria-Targeted Therapeutics for Alzheimer's Disease: The Good, the Bad, the Potential.
    Mi Y; Qi G; Brinton RD; Yin F
    Antioxid Redox Signal; 2021 Mar; 34(8):611-630. PubMed ID: 32143551
    [No Abstract]   [Full Text] [Related]  

  • 10. White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease.
    Klosinski LP; Yao J; Yin F; Fonteh AN; Harrington MG; Christensen TA; Trushina E; Brinton RD
    EBioMedicine; 2015 Dec; 2(12):1888-904. PubMed ID: 26844268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A unifying hypothesis of Alzheimer's disease. IV. Causation and sequence of events.
    Heininger K
    Rev Neurosci; 2000; 11 Spec No():213-328. PubMed ID: 11065271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondria and Oxidative Stress as a Link between Alzheimer's Disease and Diabetes Mellitus.
    Veselov IM; Vinogradova DV; Maltsev AV; Shevtsov PN; Spirkova EA; Bachurin SO; Shevtsova EF
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventions.
    Yao J; Rettberg JR; Klosinski LP; Cadenas E; Brinton RD
    Mol Aspects Med; 2011 Aug; 32(4-6):247-57. PubMed ID: 22024249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease.
    Austad SN; Ballinger S; Buford TW; Carter CS; Smith DL; Darley-Usmar V; Zhang J
    Acta Pharm Sin B; 2022 Feb; 12(2):511-531. PubMed ID: 35256932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular factors and mitochondrial dysfunction: a central role in the pathogenesis of Alzheimer's disease.
    Orsucci D; Mancuso M; Ienco EC; Simoncini C; Siciliano G; Bonuccelli U
    Curr Neurovasc Res; 2013 Feb; 10(1):76-80. PubMed ID: 23151073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Target to Alleviate Mitochondrial Dysfunctions in Alzheimer's Disease: Recent Advances and Therapeutic Implications.
    Rahman MA; Rahman MDH; Rhim H; Kim B
    Curr Neuropharmacol; 2024; 22(12):1942-1959. PubMed ID: 39234772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance of mitochondrial homeostasis for Alzheimer's disease: Strategies and challenges.
    Han Y; Liu D; Cheng Y; Ji Q; Liu M; Zhang B; Zhou S
    Redox Biol; 2023 Jul; 63():102734. PubMed ID: 37159984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial links between brain aging and Alzheimer's disease.
    Wilkins HM; Swerdlow RH
    Transl Neurodegener; 2021 Sep; 10(1):33. PubMed ID: 34465385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism: A Novel Shared Link between Diabetes Mellitus and Alzheimer's Disease.
    Sun Y; Ma C; Sun H; Wang H; Peng W; Zhou Z; Wang H; Pi C; Shi Y; He X
    J Diabetes Res; 2020; 2020():4981814. PubMed ID: 32083135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.